Search - tctmd.com

Displaying 41 - 60 of 229

Sort: Relevancy | Date

Atherosclerosis Progression May Share Traits With Tumor Growth

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

May 08, 2024

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

Wearable-Tracked Walking Behavior Hints at Subclinical HF

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

April 23, 2024

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

News Daily News

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

April 17, 2024

Secondhand Smoke Tied to Higher Risk of Incident AF

News Conference News EHRA 2024

Secondhand Smoke Tied to Higher Risk of Incident AF

April 07, 2024

April 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

April 01, 2024

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

News Conference News

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

Yael L. Maxwell

March 26, 2024

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

March 15, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

February 13, 2024

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

November 20, 2023

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Presentation AHA 2023

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Presenter: Jeff Healey

November 16, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

News Daily News

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

September 25, 2023

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

September 18, 2023

September 2023 News Roundup

News Opinion CV Team Dispatch

September 2023 News Roundup

September 01, 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

August 30, 2023

August 2023 News Roundup

News Opinion CV Team Dispatch

August 2023 News Roundup

August 01, 2023

Pitavastatin Cuts MACE in HIV-Infected Patients REPRIEVE

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.